These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 26666800

  • 21. Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines.
    Davidson JF, Donohue JF, Ohar JA.
    Expert Opin Drug Saf; 2015 Feb; 14(2):317-24. PubMed ID: 25598422
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. vilanterol + fluticasone (RELVAR Ellipta). Asthma and COPD: yet another beta-2 agonist and corticosteroid combination.
    Prescrire Int; 2016 Apr; 25(170):94. PubMed ID: 27186620
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
    Matera MG, Rogliani P, Rinaldi B, Cazzola M.
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):35-41. PubMed ID: 25382021
    [Abstract] [Full Text] [Related]

  • 28. Triple fixed inhaled therapy in frequent chronic obstructive pulmonary disease exacerbators: potential advantages for various degrees of airways obstruction.
    Antohe I, Antoniu SA, Gavrilovici C.
    Expert Opin Pharmacother; 2018 Feb; 19(3):287-289. PubMed ID: 29271268
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
    Maleki-Yazdi MR, Kaelin T, Richard N, Zvarich M, Church A.
    Respir Med; 2014 Dec; 108(12):1752-60. PubMed ID: 25458157
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi.
    Calzetta L, Rogliani P, Facciolo F, Rendina E, Cazzola M, Matera MG.
    Eur J Pharmacol; 2017 Oct 05; 812():147-154. PubMed ID: 28716723
    [Abstract] [Full Text] [Related]

  • 33. Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy.
    Lal C, Strange C.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct 05; 12():135-140. PubMed ID: 28115838
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.
    Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct 05; 12():997-1008. PubMed ID: 28392684
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sensory-mechanical effects of a dual bronchodilator and its anticholinergic component in COPD.
    O'Donnell DE, Elbehairy AF, Faisal A, Neder JA, Webb KA, Canadian Respiratory Research Network (CRRN).
    Respir Physiol Neurobiol; 2018 Jan 05; 247():116-125. PubMed ID: 28993264
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.
    Singh D, Maleki-Yazdi MR, Tombs L, Iqbal A, Fahy WA, Naya I.
    Int J Chron Obstruct Pulmon Dis; 2016 Jan 05; 11():1413-24. PubMed ID: 27445468
    [Abstract] [Full Text] [Related]

  • 40. COPD 2017: A Year in Review.
    Crisafulli E, Torres A.
    COPD; 2018 Apr 05; 15(2):118-122. PubMed ID: 29583021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.